Cannabis Advertising Restrictions in Germany
Germany's 2024 partial legalization did not open the door to cannabis marketing — advertising remains broadly prohibited under the KCanG and medical drug law.
Germany legalized personal possession and cannabis social clubs in April 2024, but the law is explicitly not consumer-friendly on marketing. Section 6 of the KCanG bans essentially all advertising and sponsorship for consumption cannabis, and medical cannabis falls under the general drug advertising ban (HWG). Fines reach €100,000+. If you run a brand, cannabis club, or media outlet in Germany, assume advertising is illegal until a lawyer tells you otherwise in writing.
What the law actually says
Germany's Konsumcannabisgesetz (KCanG), in force since 1 April 2024, legalized limited personal possession, home cultivation, and non-profit cannabis social clubs (Anbauvereinigungen). It did not create a commercial retail market, and it explicitly forbids marketing.
KCanG § 6 prohibits advertising (Werbung) and sponsorship (Sponsoring) for cannabis and for cannabis social clubs [1][2]. The ban covers:
- Product advertising for cannabis intended for consumption
- Advertising for cannabis social clubs themselves
- Sponsorship of events, activities, or persons by clubs or in connection with cannabis
Only narrowly defined factual information by a club to its members (e.g. opening hours, member communications) is permitted [1]. Any promotional framing — imagery, lifestyle appeals, price promotions, discount offers — is out.
Violations are administrative offenses under KCanG § 36, with fines up to €100,000 [2]. Strong evidence
Medical cannabis: a separate, equally strict regime
Medical cannabis (flower and extracts prescribed under the Betäubungsmittelgesetz framework, and since April 2024 partly descheduled) is regulated as a medicinal product. Advertising is governed by the Heilmittelwerbegesetz (HWG) — the German Medicines Advertising Act.
HWG § 10 prohibits advertising prescription-only medicines to the general public [3]. Because medical cannabis preparations require a prescription, consumer-facing ads (Google Ads, Instagram posts, billboards, influencer content) are illegal. Advertising directed at healthcare professionals (Fachkreise) is allowed but tightly regulated as to content, disclaimers, and truthfulness [3].
Telemedicine platforms that emerged after April 2024 have faced repeated warnings and cease-and-desist letters from competitors and consumer protection associations for pushing the boundaries of HWG § 10 [4]. Strong evidence
What this means in practice
Concrete examples of what is prohibited under current German law:
- Cannabis social clubs cannot run Instagram or TikTok accounts that promote membership with imagery of cannabis, lifestyle photography, or testimonials. Neutral factual websites are the norm [1].
- Seed banks and grow-shops must not advertise seeds or equipment with reference to psychoactive cannabis cultivation for consumption; commercial seed sales for consumption cultivation remain a legally grey area that the KCanG did not fully resolve [2][5].
- Media outlets can editorially cover cannabis, but paid promotion, affiliate deals, and sponsored content from clubs or medical providers are risky.
- Telemedicine clinics prescribing medical cannabis cannot advertise the medicine itself to consumers; some have been sued for indirect promotion via SEO landing pages [4].
- CBD products marketed as food or cosmetics fall under separate food/cosmetic law and the Novel Food Regulation, not KCanG — but health claims are heavily restricted under EU Regulation 1924/2006 [6]. Strong evidence
Enforcement and case law so far
Enforcement is mostly delegated to the Länder (states), and practice varies. Bavaria has signaled aggressive enforcement; Berlin and North Rhine-Westphalia have been more focused on club licensing than ad policing. Consumer protection associations (Wettbewerbszentrale, Verbraucherzentralen) also file civil suits under the Act Against Unfair Competition (UWG) for illegal advertising, which is often faster than administrative action [4][7].
As of the last verification date, published case law specifically on KCanG § 6 is still thin — the statute is new. Analogies are being drawn to tobacco and alcohol advertising jurisprudence and to established HWG case law [7]. Weak / limited
What is still unclear
Several questions have no settled answer as of the last verification date:
- Cross-border advertising: Whether foreign-based platforms targeting German users (e.g. a Dutch coffeeshop or a Canadian LP) fall under KCanG § 6 is untested. General principles of German media law suggest yes if the audience is targeted in Germany [2]. Weak / limited
- Educational content vs. advertising: The line between harm-reduction education (permitted) and promotion (forbidden) is not defined in the statute [1]. Disputed
- Pillar 2 (regional commercial pilots): The originally planned second pillar of German legalization, allowing licensed commercial sales in pilot regions, has stalled politically. If it ever passes, an advertising framework more like tobacco law is expected — but this is speculation, not law [8]. No data
This is not legal advice
This article is informational only and is not legal advice. Cannabis law in Germany is changing quickly; the KCanG has been in force less than two years, case law is thin, and political proposals to tighten or loosen the regime are ongoing. If you are running a business, cannabis social club, media property, or clinical practice touching cannabis in Germany, consult a qualified German lawyer (Rechtsanwalt) with regulatory experience.
Information last verified: 2025. Check the current version of the KCanG on gesetze-im-internet.de before relying on anything above.
Sources
- Government Konsumcannabisgesetz (KCanG), § 6 Werbe- und Sponsoringverbot. Bundesministerium der Justiz.
- Government Konsumcannabisgesetz (KCanG), full text. Bundesministerium der Justiz.
- Government Heilmittelwerbegesetz (HWG), § 10 — Verbot der Publikumswerbung für verschreibungspflichtige Arzneimittel. Bundesministerium der Justiz.
- Reported Legal Tribune Online (LTO), coverage of cease-and-desist actions and competition litigation against cannabis telemedicine providers in Germany, 2024–2025.
- Government Bundesministerium für Gesundheit (BMG), FAQ zum Cannabisgesetz.
- Government Regulation (EC) No 1924/2006 of the European Parliament and of the Council on nutrition and health claims made on foods.
- Government Gesetz gegen den unlauteren Wettbewerb (UWG). Bundesministerium der Justiz.
- Reported Deutsche Welle and Tagesschau reporting on the delayed 'second pillar' of German cannabis legalization and regional commercial pilots, 2024.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.